Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
10.1007/s00203-017-1459-x Summary Keywords gut microbiota, gastrointestinal diseases, cancer, therapy, dysbiosis Citation Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman SU, Suleman, Ullah I, Hassan IU, Tian Y and Li K (2025) Gut microbiota therapy in gastrointestinal diseases
Only change if side effects or clear issues
Human pharmacokinetics, doseresponse, and mechanism validation remain limited
Bogliun G, Marzorati L, Cavaletti G, Frattola L
These data, together with the results of the microscopic analysis of sym40-1 nodules treated with 0.1 mM GSH, where a decrease in the size of hypertrophied infection droplets was observed, as well as the fact that the highest hGSH content was detected in sym33-3 nodules, where infection threads rarely formed infection droplets, suggest that hGSH may play a role in infection droplet formation
Supports Extracellular Matrix Remodeling The extracellular matrix (ECM) provides structural and biochemical support to surrounding cells
US$ 22.52
US$ 24.11
US$ 25.42
US$ 24.97